Preeclampsia in infertile patients subjected to homologous and heterologous insemination in the Centro de Biomedicina Reproductiva del Valle - Fecundar, Cali, Colombia

Authors

  • Jaime Saavedra-Saavedra
  • Eliana Paredes-Becerra
  • Paola Recalde-Losada

DOI:

https://doi.org/10.18597/rcog.203

Keywords:

Preeclampsia, intrauterine insemination (IUI), donor semen

Abstract

Objective: Determining preeclampsia incidence and risk in infertile patients who have been inseminated with semen from a donor or from their partner.

Materials and methods: This study dealt with historical cohorts of patients who had been subjected to homologous or heterologous intrauterine insemination in the Fecundar infertility centre and who had managed to become pregnant for more than 20 weeks gestation between January 2000 and 31st December 2009. Patients suffering endocrine and metabolic disorders (diabetes mellitus, collagen diseases) or chronic diseases (arterial hypertension, thrombophilia) were excluded. Sample size was 155 patients regarding heterologous insemination and 310 for homologous insemination.The presence of preeclampsia and perinatal result were evaluated and type of insemination, age, ethnicity, educational level, body mass index (BMI in Kg/m²), indication of insemination, number of prior cycles and socioeconomic strata were also measured. Accumulated incidence was estimated and two cohorts were compared by RR with respective confidence intervals. Females were stratified by age.

Results: 428 females fulfilled the selection criteria. There was 6% (24/428) preeclampsia incidence, 4% (11/264) homologous IUI and 7.93% (13/164) heterologous IUI. No differences were found regarding the risk of preeclampsia according to the type of insemination and after being adjusted for age (1.18 RR; 0.54-2.58 95%CI).

Conclusions: Greater preeclampsia incidence was found in heterologous IUI; however, there was no association with the development of preeclampsia.

Author Biographies

Jaime Saavedra-Saavedra

Profesor titular de Ginecología y Obstetricia, Universidad del Valle. Especialista en Medicina Reproductiva. Profesor Universidad Libre. Director general del Centro de Biomedicina Reproductiva del Valle - Fecundar, Cali, Colombia.

Eliana Paredes-Becerra

Residente IV año de Ginecología y Obstetricia, Universidad Libre Seccional Cali, Cali, Colombia.

Paola Recalde-Losada

Residente IV año de Ginecología y Obstetricia, Universidad Libre Seccional Cali, Cali, Colombia.

References

Cifuentes R. Preeclampsia-eclampsia. Diagnóstico y manejo. En: Ginecología y Obstetricia Basadas en las Nuevas Evidencias, 2da ed. Bogotá: Ed. Distribuna; 2009. p. 345-48.

Instituto Nacional de Salud, Vigilancia y Control en Salud Pública: Protocolo de Vigilancia y Control de Mortalidad Materna; Grupo de vigilancia y control de enfermedades no transmisibles. Bogotá: INS, DANE; 2009.

Granados G. Mortalidad materna en Colombia: un grave problema de salud pública. Naciones Unidas en Colombia: Boletín Informativo. Bogotá mayo 5 del 2010.

Marañón T. Estudio de algunos factores de riesgo de preeclampsia-eclampsia. Análisis multivariado. Revista Electrónica de Portales Médicos.com. 2009; 4:1-4.

Chen XK, Wen SW, Bottomley J, Smith GN, Leader A, Walker MC. In vitro fertilization is associated with an increased risk for preeclampsia. Hypertens Pregnancy 2009;28:1-12.

Dechend R. Activating auto-antibodies against the AT1 receptor in preeclampsia. Autoimmunity Reviews 2005;4:61-5.

Ness R. Male reproductive proteins and reproductive outcomes. Am J Obstet Gynecol 2008;198:620-4.

Dekker G. The partner’s role in the etiology of preeclampsia. J Reprod Immunol 2002:57:203-15.

Robertson S. Seminal ‘priming’ for protection from preeclampsia a unifying hypothesis. J Reprod Immunol 2003;59:253-65.

Athanassakis I, Vassiliadis S. Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancy. Immunology 2002;107:281-7.

Basso O, Christensen K, Olsen J. Higher risk of preeclampsia after change of partner. An effect of longer interpregnancy intervals? Epidemiology 2001;12: 624-9.

Need J, Bell B, Meffin E. Pre-eclampsia in pregnancies from donor inseminations. J Reprod Immnol 1983;5:329-38.

Smith G, Mark W, Julie L. Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. Am J Obstet Gynecol 1997;2:455-9.

Shevell T, Malone FD, Vidaver J, Porter TF, Luthy DA, Comstock CH, et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol 2005;106:1039-45.

Kyrou D, Kolibianakis EM, Devroey P, Fatemi HM. Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? Fertil Steril 2010;93:1124-27.

Hoy J, Venn A, Halliday J, Kovacs G, Waalwyk K. Perinatal and obstetric outcomes of donor insemination using cryopreserved semen in Victoria, Australia. Hum Reprod 1999;14:1760-4.

How to Cite

1.
Saavedra-Saavedra J, Paredes-Becerra E, Recalde-Losada P. Preeclampsia in infertile patients subjected to homologous and heterologous insemination in the Centro de Biomedicina Reproductiva del Valle - Fecundar, Cali, Colombia. Rev. colomb. obstet. ginecol. [Internet]. 2012 Mar. 30 [cited 2024 May 17];63(1):57-63. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/203

Downloads

Download data is not yet available.

Published

2012-03-30

Issue

Section

Original Research
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views

Some similar items: